Trials / Unknown
UnknownNCT03933748
Therapeutic Drug Monitoring of Teicoplanin in Children
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Shandong University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In this study, the therapeutic drug monitoring of teicoplanin is carried out among children to obtain the drug concentration, clinical efficacy and safety data of children patients in different gender and age groups. Then we analyze the relationship between blood drug concentration and efficacy and safety, and provide recommendations for the treatment window of teicoplanin in Chinese children.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Teicoplanin-PMMA | Therapeutic drug monitoring of teicoplanin |
Timeline
- Start date
- 2019-04-01
- Primary completion
- 2025-11-01
- Completion
- 2025-12-01
- First posted
- 2019-05-01
- Last updated
- 2020-04-14
Locations
1 site across 1 country: China
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03933748. Inclusion in this directory is not an endorsement.